Compare Amgen, Inc. (AMGN) vs QUALCOMM, Inc. (QCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs QUALCOMM, Inc. — how do they compare? Amgen, Inc. trades at $356.86 (market cap $196.12B), while QUALCOMM, Inc. trades at $186.83 (market cap $199.37B). The key difference: Amgen, Inc. and QUALCOMM, Inc. are close in size by market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | QCOM | |
|---|---|---|
Market Cap | $196.12B | $199.37B |
Sector | Health | Technology |
52-Week High | $388.16 | $251.10 |
52-Week Low | $271.18 | $124.07 |
Enterprise Value | $241.41B | $204.85B |
Dividend Yield | 2.77% | 1.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Qualcomm (QCOM) trades at $189.16, down 1.01% over the past 24 hours, with a bullish technical signal from moving averages and a neutral oscillator reading. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $2.65 exceeding the $2.56 estimate. Revenue for 2025 reached $44.28 billion, though net income margin compressed to 12.51% from prior years. Recent news highlights Qualcomm's push into AI and data centers, including the 'Dragonfly' AI brand launch at COMPUTEX 2026.
The outlook for QCOM is cautiously optimistic, with a consensus price target of $221.21 implying 17% upside. Opportunities include diversification into automotive and AI inference markets, but risks persist from smartphone demand softness and competitive pressure from Nvidia's entry into PC chips. Analyst sentiment is mixed, with 42.65% buy ratings amid margin concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →
